基于病史的LMP-SURE工具自我判定药物流产资格而无需超声检查
本研究在阿拉斯加、夏威夷、爱达荷和犹他州的计划生育诊所招募1026名参与者,其中781名符合条件并完成LMP-SURE自我筛查工具。该工具识别出493名(65.1%)无需超声即可进行药物流产的参与者,灵敏度83.8%(95%CI 73.1-90.8),特异度70.0%(95%CI 66.4-73.3),假阴性率1.5%。作者认为该工具可安全减少药物流产前超声检查的需求。
要点
- LMP-SURE自我筛查工具灵敏度83.8%、特异度70.0%,假阴性率1.5%。
- 仅11名(1.5%)经工具判定合格者被超声判定为不合格。
- 冲突病例中6名(0.8%)孕龄超过77天,2名(0.3%)异位妊娠均被工具识别需超声。
核心结论
- 这种面向患者、简短、基于病史的筛查工具可以安全地减少药物流产前超声检查的需求。
研究设计与样本
- 研究设计了患者自填的五问题筛查工具LMP-SURE,评估孕龄及与孕龄误判或异位妊娠相关的因素。
- 从阿拉斯加、夏威夷、爱达荷和犹他州的计划生育诊所招募既往未行超声检查的参与者完成包含LMP-SURE的简短调查,然后通过病历回顾获取超声孕龄。
- 共同意1026名参与者,其中781名符合入组要求并完成工具。
主要发现
- 使用LMP-SURE工具,识别出493名参与者(65.1%)无需超声即可进行药物流产。
- LMP-SURE工具灵敏度(正确识别不适合药物流产患者的能力)为83.8%(95%CI 73.1-90.8),特异度(正确识别适合药物流产患者的能力)为70.0%(95%CI 66.4-73.3)。
- 阴性似然比(LMP-SURE判定合格者中超声判定不合格与超声判定合格的比值)为0.23(95%CI 0.13-0.40),假阴性百分比为1.5%。
- 仅11名患者(1.5%)经LMP-SURE工具判定为无需超声即可进行药物流产合格,但被超声检查发现不合格;冲突病例中6名(0.8%)孕龄超过77天。
- 两名参与者(0.3%)诊断为异位妊娠,均被LMP-SURE识别为需要超声检查。
临床怎么用
- 作者认为该工具可安全地减少药物流产前超声检查的需求。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate a self-screening eligibility tool for medication abortion without an ultrasonogram. METHODS: We designed a patient-administered, five-question screening tool (LMP-SURE) that assesses gestational age plus factors associated with misdating or ectopic pregnancy. We recruited participants without prior ultrasonograms from family planning clinics in Alaska, Hawai'i, Idaho, and Utah to complete a brief survey including LMP-SURE and then obtained ultrasound dating by chart review. We compared eligibility for medication abortion by ultrasonogram with eligibility by the LMP-SURE screening tool. RESULTS: We consented 1,026 participants; 781 met eligibility requirements and completed the tool. Using the LMP-SURE tool, we identified 493 participants (65.1%) eligible for medication abortion without an ultrasonogram. The LMP-SURE tool sensitivity (ability to correctly identify a patient ineligible for medication abortion) was 83.8% (95% CI, 73.1-90.8), specificity (ability to correctly identify a patient eligible for medication abortion) was 70.0% (95% CI, 66.4-73.3), likelihood ratio (-) (probability of someone eligible by LMP-SURE to be ineligible by ultrasonogram vs eligible by ultrasonogram) was 0.23 (95% CI, 0.13-0.40), and percentage of false-negatives was 1.5%. Only 11 patients (1.5%) who met eligibility for medication abortion without an ultrasonogram by the LMP-SURE tool were found ineligible for medication abortion by their ultrasonogram. Of those with conflicts, six (0.8%) had a gestational age beyond 77 days. The two participants (0.3%) diagnosed with ectopic pregnancies both required ultrasonograms by LMP-SURE. CONCLUSION: This patient-facing, brief, history-based screening tool can safely minimize the need for ultrasonogram before medication abortion.
引用
- Kerestes C, Tschann M, Pearlman Shapiro M, et al. Self-Determination of Eligibility for Medication Abortion Without Ultrasonography Using a History-Based Tool: LMP-SURE. Obstet Gynecol. 2024. PMID: 39053008. doi:10.1097/AOG.0000000000005675
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。